XPH

SPDR S&P Pharmaceuticals ETF

Up$47.58
+$0.08
(+0.17%)
As of 2:47:14 PM EDT | 1/22/20  |  Market Open

XPH Trading Data

Open

$47.6

Low Price

$47.35

High Price

$47.83

Previous Last Price

$47.5

Bid Size

$47.58 X 1500

Ask Size

$47.61 X 800

XPH Portfolio Data

AUM

$233,996,000

Shares

4,950

PE Ratio

11.44

Price / Book Ratio

3.23

Expense Ratio

0.35

Net Asset Value

$47.27

Volume

Volume

38,510

Avg. Volume (YDT)

71,754

Dollar Volume

$2,179,880

Weekly Avg. Volume

92,212

Monthly Avg. Volume

92,088

Quarterly Avg. Volume

87,953

XPH Fund Description

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

XPH Chart

XPH Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Pharmaceuticals ETF

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

XPH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XPH Holdings

Top 10 Holdings

Eli Lilly and Company (LLY)
4.67%
Horizon Therapeutics Public Limited Company (HZNP)
4.64%
Mylan N.V. (MYL)
4.6%
Zoetis Inc. Class A (ZTS)
4.58%
Perrigo Co. Plc (PRGO)
4.45%
Endo International Plc (ENDP)
4.41%
Elanco Animal Health Inc. (ELAN)
4.39%
Nektar Therapeutics (NKTR)
4.3%
Pfizer Inc. (PFE)
4.3%
Johnson & Johnson (JNJ)
4.29%

Total XPH Holdings

Total Holdings: 43

Eli Lilly and Company (LLY)
4.67%
Horizon Therapeutics Public Limited Company (HZNP)
4.64%
Mylan N.V. (MYL)
4.6%
Zoetis Inc. Class A (ZTS)
4.58%
Perrigo Co. Plc (PRGO)
4.45%
Endo International Plc (ENDP)
4.41%
Elanco Animal Health Inc. (ELAN)
4.39%
Nektar Therapeutics (NKTR)
4.3%
Pfizer Inc. (PFE)
4.3%
Johnson & Johnson (JNJ)
4.29%
Catalent Inc (CTLT)
4.28%
Bristol-Myers Squibb Company (BMY)
4.25%
Allergan plc (AGN)
4.16%
Reata Pharmaceuticals Inc. Class A (RETA)
4.16%
Jazz Pharmaceuticals Plc (JAZZ)
4.15%
Merck & Co. Inc. (MRK)
4.15%
Axsome Therapeutics Inc. (AXSM)
4.1%
Aerie Pharmaceuticals Inc. (AERI)
2.98%
Pacira Biosciences Inc. (PCRX)
2.15%
Zogenix Inc. (ZGNX)
2.11%
MyoKardia Inc. (MYOK)
2.1%
Intra-Cellular Therapies Inc. (ITCI)
1.7%
Supernus Pharmaceuticals Inc. (SUPN)
1.64%
Cara Therapeutics Inc (CARA)
1.39%
Prestige Consumer Healthcare Inc (PBH)
1.38%
ANI Pharmaceuticals Inc. (ANIP)
1.16%
Corcept Therapeutics Incorporated. (CORT)
1.1%
TherapeuticsMD Inc. (TXMD)
1.05%
Arvinas Inc. (ARVN)
0.9%
Revance Therapeutics Inc. (RVNC)
0.82%
Innoviva Inc. (INVA)
0.79%
Intersect ENT Inc (XENT)
0.75%
Tricida Inc (TCDA)
0.73%
Omeros Corporation (OMER)
0.72%
Collegium Pharmaceutical Inc. (COLL)
0.59%
Theravance Biopharma Inc (TBPH)
0.57%
Phibro Animal Health Corporation Class A (PAHC)
0.51%
Amphastar Pharmaceuticals Inc (AMPH)
0.47%
BioDelivery Sciences International Inc. (BDSI)
0.38%
Wave Life Sciences Ltd. (WVE)
0.11%
STATE STREET INSTITUTIONAL LIQ STATE STR (70286227)
0.08%
SPDR SPDR S & P Pharmaceuticals ETF (XPH)
0%
U.S. Dollar
0%

XPH Technicals

Alpha

-11.36

Beta

1.37

Leverage

Long

Standard Deviation

2.7

XPH Dividends

Dividend Date

2019-12-23

Latest Dividend

0.071

Annual Dividend

0.29

Annual Dividend Rate

0.29

Annual Dividend Yield

0.62

XPH Performance

YTD Return

4.18%

1 Year Return

20%

3 Year Return

24.9%

5 Year Return

-14.71%

10 Year Return

148.5%

XPH Related Articles

4 Hot Pharmaceutical ETFs

4 Hot Pharmaceutical ETFs

Pharmaceutical ETFs invest in stocks of companies that are involved in the research, development, manufacture, sale or distribution of pharmaceuticals…

© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.